"This could be an important step toward the preservation of more complex tissues and structures," said Adam Higgins, an associate professor in the Oregon State University School of Chemical, Biological and Environmental Engineering in US.
Cryopreservation has already found widespread use preserving semen, blood, embryos, plant seeds and some other biological applications.
However, it is often constrained by the crystallisation that occurs when water freezes, which can damage or destroy tissues and cells, Higgins said.
To address this, researchers have used various types of cryoprotectants that help reduce cell damage during the freezing process - among them is ethylene glycol, the compound often used in automobile radiators to prevent freezing.
More From This Section
One problem is that many of these cryoprotectants are toxic, and can damage or kill the very cells they are trying to protect from the forces of extreme cold, Higgins said.
Scientists developed a mathematical model to simulate the freezing process in the presence of cryoprotectants, and identified a way to minimise damage.
The research showed that healthy cell survival following vitrification rose from about 10 per cent with a conventional approach to more than 80 per cent with the new optimised procedure.
"The biggest single problem and limiting factor in vitrification is cryoprotectant toxicity, and this helps to address that," Higgins said.
"The model should also help us identify less toxic cryoprotectants, and ultimately open the door to vitrification of more complex tissues and perhaps complete organs," he said.
Tissues could be made in small amounts and then stored until needed for transplantation. Organs being used for transplants could be routinely preserved until a precise immunological match was found for their use.
Conceptually, a person could even grow a spare heart or liver from their own stem cells and preserve it through vitrification in case it was ever needed, Higgins said.
The study was published in the journal PLOS ONE.